Truist Financial Corp Decreases Stake in HCA Healthcare, Inc. $HCA

Key Points

• Truist Financial trimmed its HCA stake by 2.1% in Q4, selling 5,841 shares and leaving 274,057 shares valued at about $127.95 million.
• Insiders have been net sellers: SVP Christopher Wyatt sold 4,000 shares and EVP Michael Cuffe sold 1,500, with insiders disposing of 15,214 shares (~$7.8M) in the last 90 days and retaining 1.5% ownership.
• Analysts and results: HCA has a "Moderate Buy" consensus with a $520.55 target despite several firms cutting price targets, and it reported EPS of $7.15 (vs. $7.19 est.) while guiding FY2026 EPS to $29.10–31.50.

Truist Financial Corp lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 274,057 shares of the company's stock after selling 5,841 shares during the quarter. Truist Financial Corp owned 0.12% of HCA Healthcare worth $127,946,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $29,000. Palisade Asset Management LLC purchased a new stake in HCA Healthcare during the third quarter valued at $26,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at $31,000. Aventura Private Wealth LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at $34,000. Finally, Key Capital Management INC purchased a new stake in HCA Healthcare during the fourth quarter valued at $35,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insiders Place Their Bets

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares of the company's stock, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the company's stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares of the company's stock, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Cantor Fitzgerald reiterated an "overweight" rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. KeyCorp reduced their price objective on HCA Healthcare from $550.00 to $510.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. Barclays reduced their price objective on HCA Healthcare from $551.00 to $496.00 and set an "overweight" rating for the company in a research report on Monday, April 27th. Wells Fargo & Company reduced their price target on HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating for the company in a research report on Monday, April 27th. Finally, Oppenheimer reduced their price target on HCA Healthcare from $540.00 to $520.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $520.55.

HCA Healthcare Stock Up 0.1%

Shares of HCA opened at $433.73 on Monday. The stock has a market cap of $96.50 billion, a price-to-earnings ratio of 14.92, a PEG ratio of 1.37 and a beta of 1.19. The business has a 50-day simple moving average of $497.66 and a two-hundred day simple moving average of $486.41. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business's revenue was up 4.3% on a year-over-year basis. During the same period last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.05 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.